Peptide
library.

A straightforward reference library for peptides and related compounds: benefits, evidence, practical use, reference dosing and clear context.

Try terms like fat loss, weight loss, recovery, collagen, focus, gut or growth hormone.

Reference ranges shown here are curated educational references, not individualized recommendations. Regulatory status and evidence vary by compound and use.

Human topical + preclinical

GHK-Cu

Naturally occurring copper-binding tripeptide researched for collagen signalling, skin quality, extracellular-matrix remodelling and tissue repair.

Reference

1–2.5 mg

3× weekly · 6–8 weeks

View peptide →
Component evidence only · blend unvalidated

GLOW

Vendor/community blend name for a co-formulation of GHK-Cu, BPC-157 and TB-500; evidence comes from the individual components rather than the three-peptide blend itself.

Reference

1.4–4.2 mg per injection; 2.8 mg is a commonly cited reference point

Daily initially, then 5×/week, then 2–3×/week in the cited 12-week protocol · 12 weeks

View peptide →
Component evidence only · blend unvalidated

KLOW

Four-peptide research blend combining GHK-Cu, BPC-157, TB-500 and KPV; the evidence base belongs to the individual components rather than the co-formulation.

Reference

1.6–4.8 mg per injection

Daily initially, then 5×/week, then 2–3×/week in the cited 12-week protocol · 12 weeks

View peptide →
Direct animal combination study · no controlled human blend evidence

BPC-157 / TB-500 (Wolverine)

Research blend name for BPC-157 + TB-500; one 2026 rat tendon study tested the combination directly, but no controlled human blend trial has established efficacy or dosing.

Reference

BPC-157 250–500 mcg daily + TB-500 1–2.5 mg 2–3× weekly

Mixed by component · 4–6 weeks

View peptide →
Mostly preclinical · very limited human data

BPC-157

Synthetic 15-amino-acid peptide with extensive animal research in tissue-repair and gastrointestinal models but very limited human evidence.

Reference

250–500 mcg daily

Daily · 4–6 weeks

View peptide →
Preclinical · no established human exposure data

TB-500

Synthetic thymosin-beta-4-related fragment researched for wound and tissue-repair biology, with no established human clinical evidence for the fragment itself.

Reference

1–2.5 mg

2–3× weekly · 4–6 weeks

View peptide →